The different characteristics of Dupuytren's disease fibroblasts derived from either nodule or cord: Expression of α-smooth muscle actin and the response to stimulation by TGF-β1

Journal of Hand Surgery

Volumn 28 B, Issue 4, 2003, Pages 351-356

  Bisson, Marcus A ^a   McGrouther, D A ^a,b   Mudera, V ^a,b   Grobbelaar, A O ^a,b  

^a MOUNT VERNON HOSPITAL   (United Kingdom)

^b ROYAL NATIONAL ORTHOPAEDIC HOSPITAL   (United Kingdom)

Author keywords

Dupuytren's constracture; Myofibroblasts; Nodule cord; Transforming growth factor 1

Indexed keywords

ALPHA ACTIN; TRANSFORMING GROWTH FACTOR BETA1;

AGED; ARTICLE; CELL CULTURE; CELL LINE; CELL STIMULATION; CONTROLLED STUDY; DISEASE COURSE; DUPUYTREN CONTRACTURE; FASCIA; FIBROBLAST; HAND SURGERY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LIGAMENT; MUSCLE CONTRACTURE; MYOFIBROBLAST; PHENOTYPE; RECURRENT DISEASE; SMOOTH MUSCLE; STAINING;

EID: 0042315074     PISSN: 02667681     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0266-7681(03)00135-9     Document Type: Article

References (35)

1. Alioto RJ, Rosier RN, Burton RI, Puzas JE (1994). Comparative effects of growth factors on fibroblasts of Dupuytren's tissue and normal palmar fascia. Journal of Hand Surgery (Am), 19A: 442-452.
2. Badalamente MA, Stern L, Hurst LC (1983). The pathogenesis of Dupuytren's contracture: Contractile mechanisms of the myofibroblasts. Journal of Hand Surgery (Am), 8A: 235-243.
3. Badalamente MA, Sampson SP, Hurst LC, Dowd A, Miyasaka K (1996). The role of transforming growth factor beta in Dupuytren's disease. Journal of Hand Surgery (Am), 21A: 210-215.
4. Baird KS, Crossan JF, Ralston SH (1993). Abnormal growth factor and cytokine expression in Dupuytren's contracture. Journal of Clinical Pathology, 46: 425-428.
5. Bazin S, Le Lous M, Duance VC, Sims TJ, Bailey AJ, Gabbiani G et al. (1980). Biochemistry and histology of the connective tissue of Dupuytren's disease lesions. European Journal of Clinical Investigation, 10: 9-16.
6. Berndt A, Kosmehl H, Mandel U, Gabler U, Luo X, Celeda D et al. (1995). TGF beta and bFGF synthesis and localization in Dupuytren's disease (nodular palmar fibromatosis) relative to cellular activity, myofibroblast phenotype and oncofetal variants of fibronectin. Histochem Journal, 27: 1014-1020.
7. Border WA, Noble NA (1994). Transforming growth factor beta in tissue fibrosis. New England Journal of Medicine, 331: 1286-1292.
8. Brickley-Parsons D, Glimcher MJ, Smith RJ, Albin R, Adams JP (1981). Biochemical changes in the collagen of the palmar fascia in patients with Dupuytren's disease. Journal of Bone Joint Surgery (Am), 63A: 787-797.
9. Brown RA, Sethi KK, Gwanmesia I, Raemdonck D, Eastwood M, Mudera V. (2002). Enhanced fibroblast contraction of 3D collagen lattices and integrin expression by TGF-beta1 and -beta3: Mechanoregulatory growth factors? Experimental Cell Research, 274: 310-322.
10. Desmoulière A, Gabbiani G (1994). Modulation of fibroblastic cytoskeletal features during pathological situations: The role of extracellular matrix and cytokines. Cell Motility and the Cytoskeleton, 29: 195-203.
11. Desmoulière A, Geinoz A, Gabbiani F, Gabbiani G (1993). Transforming growth factor-beta 1 induces alpha-smooth muscle actin expression in granulation tissue myofibroblasts and in quiescent and growing cultured fibroblasts. Journal of Cell Biology, 122: 103-111.
12. Dugina V, Fontao L, Chaponnier C, Vasiliev J, Gabbiani G (2001). Focal adhesion features during myofibroblastic differentiation are controlled by intracellular and extracellular factors. Journal of Cell Science, 114: 3285-3296.
13. Eastwood M, McGrouther DA, Brown RA (1994). A culture force monitor for measurement of contraction forces generated in human dermal fibroblast cultures: Evidence for cell-matrix mechanical signalling. Biochimica Biophysics Acta, 1201: 186-192.
14. Gabbiani G, Majno G (1972). Dupuytren's contracture: Fibroblast contraction? An ultrastructural study. American Journal of Pathology, 66: 131-146.
15. Gelberman RH, Amiel D, Rudolph RM, Vance RM (1980). Dupuytren's contracture. An electron microscopic, biochemical, and clinical correlative study. Journal of Bone and Joint Surgery (Am), 62A: 425-432.
16. Grinnell F, Zhu M, Carlson MA, Abrams JM (1999). Release of mechanical tension triggers apoptosis of human fibroblasts in a model of regressing granulation tissue. Experimental Cell Research, 248: 608-619.
17. Hinz B, Celetta G, Tomasek JJ, Gabbiani G, Chaponnier C (2001). Alpha-smooth muscle actin expression upregulates fibroblast contractile activity. Molecular Biology of Cell, 12: 2730-2741.
18. Ignotz RA, Massague J (1986). Transforming growth factor-beta stimulates the expression of fibronectin and collagen and their incorporation into the extracellular matrix. Journal of Biological Chemistry, 261: 4337-4345.
19. Kloen P, Jennings CL, Gebhardt MC, Springfield DS, Mankin HJ. (1995). Transforming growth factor-beta: Possible roles in Dupuytren's contracture. Journal of Hand Surgery (Am), 20A: 101-108.
20. Leclercq C. Associated conditions. In: Tubiana R, Leclercq C, Hurst LC, Badalamante MA, Mackin EJ (Eds) Dupuytren's Disease. London, Martin Dunitz, 2000: 108-116
21. Luck JV (1959). Dupuytren's contracture - A new concept of the pathogenesis correlated with the surgical management. Journal of Bone and Joint Surgery (Am), 41A: 635-664.
22. Mikkelson OA. Epidemiology of a Norwegian population. In: McFarlane RM, McGrouther DA, Flint MH (Eds.) Dupuytren's Disease, Biology and Treatment. Edinburgh, London, Melbourne, New York, Churchill Livingstone, 1990: 191-200.
23. Montesano R, Orci L (1988). Transforming growth factor beta stimulates collagen-matrix contraction by fibroblasts: Implications for wound healing. Proceedings of the National Academy of Science USA, 85: 4894-4897.
24. Pasquali-Rochetti I, Guerra D, Baccarani-Contri M, Fornieri C, Mori G, Marcuzzi A et al. (1993). A clinical, ultrastructural and immunochemical study of Dupuytren's disease. Journal of Hand Surgery (Br), 18B: 262-269.
25. Petrov VV, Fagard RH, Lijnen PJ (2002). Stimulation of collagen production by transforming growth factor-beta1 during differentiation of cardiac fibroblasts to myofibroblasts. Hypertension, 39: 258-263.
26. Qureshi FI, Hornigold R, Spencer JD, Hall SM (2001). Langerhans cells in Dupuytren's contracture. Journal of Hand Surg (Br), 26B: 362-367.
27. Rayan GM (1999). Clinical presentation and types of Dupuytren's disease. Hand Clinics, 15: 87-96.
28. Reed MJ, Vernon RB, Abrass IB, Sage EH (1994). TGF-beta 1 induces the expression of type I collagen and SPARC, and enhances contraction of collagen gels, by fibroblasts from young and aged donors. J Cell Physiology, 158: 169-179.
29. Serini G, Gabbiani G (1999). Mechanisms of myofibroblast activity and phenotypic modulation. Experimental Cell Research, 250: 273-283.
30. Skalli O, Ropraz P, Trzeciak A, Benzonana G, Gillessen D, Gabbiani G (1986). A monoclonal antibody against alpha-smooth muscle actin: A new probe for smooth muscle differentiation. Journal of Cell Biology, 103: 2787-2796.
31. Tomasek JJ, Gabbiani G, Hinz B, Chaponnier C, Brown RA (2002). Myofibroblasts and mechano-regulation of connective tissue remodelling. National Reviews on Molecular Cell Biology, 3: 349-363.
32. Tomasek J, Rayan GM (1995). Correlation of alpha-smooth muscle actin expression and contraction in Dupuytren's disease fibroblasts. Journal of Hand Surgery (Am), 20A: 450-455.
33. Vande Berg JS, Gelberman RH, Rudolph R, Johnson D, Sicurello P (1984). Dupuytren's disease: Comparative growth dynamics and morphology between cultured myofibroblasts (nodule) and fibroblasts (cord). Journal of Orthopaedic Research, 2: 247-256.
34. Vaughan MB, Howard EW, Tomasek JJ (2000). Transforming growth factor-beta1 promotes the morphological and functional differentiation of the myofibroblast. Experimental Cell Research, 257: 180-189.
35. Zamora RL, Heights R, Kraemer BA, Erlich HP, Groner JP (1994). Presence of growth factors in palmar and plantar fibromatoses. Journal of Hand Surgery (Am), 19A: 435-441.